Skip to main content

Table 2 Analysis of lymphocyte subpopulations by flow cytometry

From: Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy

Lymphocyte subpopulations

Cases

Controls

P

CD3+ T (%)

62.3 (53.8–68.2)

73.3 (65.4–81.5)

0.017

CD4+ T (%)

34.4 (27.9–41.5)

42.8 (34.5–52.8)

0.024

CD8+ T (%)

21.1 (14.5–25.1)

23.1 (15.1–29.1)

0.820

NK (%)

9.0 (3.8–14.1)

6.8 (2.1–9.6)

0.278

NKT (%)

3.2 (1.0–12.0)

1.0 (0.7–2.8)

0.049

CD19+ B cells (%)

13.0 (9.0–16.0)

9.7 (7.2–15.1)

0.532

  1. Cells are reported as % of total lymphocytes. Values in cases and controls are reported as median (IQR)